Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2001 | L-alanosine. Drug Report for Invest | Yu, J | Drugs Database 18, 1月9日 | | | |
2006 | Living cells as test tubes. | Xie, XS; Yu, J; Yang, WY | Science 312(5771), 228-230 | | | |
2010 | Mesenchymal stem cell-like characteristics of human phyllodes tumors. | Lin, JJ; Yu, J; Huang, CS; Yeh, KT; Lien, HC; Chou, FP; Chang, WY; Yu, A. L. | | | | |
2010 | Neovasculogenic potential of breast cancer stem cells. | Hsieh, H-C; Yu, AL; Yu, J; Chang, W-W | | | | |
2010 | Novel production system of vaccine. | Huang, Y-K; Gu, S-Y; Liu, Y-L; Wang, Y-C; Lin, K-H; Yu, J; Ling, T-Y | | | | |
2008 | Oct-4 silencing leads to nuclear export of olig2, activation of stat3 signaling, and astrocytic differentiation in human ntera-2 cells | Lin, Y. P; Hsu, T. C; Lin, K. I; Yu, J | | | | |
2008 | Oct-4 silencing leads to nuclear export of olig2, activation of stat3 signaling, and astrocytic differentiation in human ntera-2 cells | Lin, Y. P; Hsu, T. C; Lin, K. I; Yu, J | | | | |
2005 | Organ-specific stem/progenitor cells and their interactions with surrounding cells. | Yu, J | | | | |
2013 | Podocalyxin-like 1 Promotes Stemness and Metastasis of Cancer Cells through Activating Cortactin | Lin, CW; Sun, MS; Liao, MY; Yu, J; Chiou, LT; Wu, HC | | | | |
2007 | Promotion of astrocyte phenotypes by suppression of Oct-4 expression | Yu, J; Lin, Y. P; Hsu, T. C; Lin, K. I | | | | |
1996 | Regulation and reconstitution of human hematopoiesis. (a review) | Yu, J | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 95, 281-293 | | | |
1973 | Selective solubilization of proteins from red blood cell membranes by protein perturbants | Steck, T. L.; Yu, J | J. Supramol. Struc 1(3), 220-232 | | | |
2010 | SH2 domain-containing inositol 5-phosphatases 2 (SHIP2) is important for the survival of human breast cancer stem cells. | Fu, C-H; Chang, W-W; Yu, AL; Yu, J | | | | |
1991 | Specific roles of activin/inhibin in human erythropoiesis in vitro. (a review) | Yu, J; Maderazo, L; Shao, LE; Frigon Jr, Normand L.; Vaughan, J; Vale, W; Yu, A. | Ann. NY Acad. Sci 628, 199-211 | | | |
2008 | Stem cell surface markers and differentiation regulators | Yu, J | | | | |
2007 | Stem Cells and Cancer | Yu, J | | | | |
2002 | Testing of new agents in childhood cancer preclinical models | Houghton, PJ; Adamson, PC; Blaney, S; Fine, HA; Gorlick, R; Haber, M; Helman, L; Hirschfeld, S; Hollingshead, MG; Israel, MA; Lock, RB; Maris, JM; Merlino, G; Patterson, W; Reynolds, CP; Shannon, K; Yu, A; Yu, J; Smith, MA. | Clin. Cancer Res 8, 3646-3657 | | | |
2008 | The Extracellular Collagenous Scaffolds Actinotrichia Regulate Vascular Plexus Formation and the Radial Pattern of Dermal Bony Rays in Zebrafish Caudal Fins | Huang, C. C; Wang, T. C; Lin, B. H; Wang, Y. W; Johnson, S. L; Yu, J | | | | |
2010 | The influence of collagen film nanostructure on pulmonary stem cells and collagen-stromal cell interactions | Huang, CJ; Chien, YL; Ling, TY; Cho, HC; Yu, J; Chang, YC. | Biomaterials 31, 8271-8280 | | | |
1990 | The inhibin/activin family of hormones and growth factor in peptide growth factors and their receptors | Vale, W.; Hsueh, A.; Rivier, C.; Yu, J | In: Handbook of Experimental Pharmacology, M.B. Sporn and A.B. Roberts (eds.) vol. 95, Spranger-Verlag, 211-248 | | | |